Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...

Analyst Evan Seigerman from BMO Capital maintained a Hold rating on Bristol-Myers Squibb (BMY – Research Report) and increased the price ...

Terence Flynn, an analyst from Morgan Stanley, maintained the Sell rating on Bristol-Myers Squibb (BMY – Research Report). The associated price target remains the same with $37.00. Terence Flynn has ...

Bristol Myers Squibb shares rose Friday, a day after its schizophrenia drug was approved for use by the Food and Drug Administration.

Bristol-Myers Squibb won FDA approval for its novel schizophrenia drug, Cobenfy. BMY stock jumped, signaling a breakout.

Bristol-Myers Squibb (NYSE:BMY) shares rallied 4.45% in premarket trading Friday following the announcement that the U.S.

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

The indictment accuses the mayor of accepting and seeking “illegal campaign contributions to his 2021 mayoral campaign, as well as other things of value, from foreign nationals.” Hurubie Meko ...

Because the Turkish airline Adams flew provided him with free travel benefits worth tens of thousands of dollars, he flew that airline even when doing so was “otherwise inconvenient,” the ...

The IAF will stop any arms transfers from Iran to Hezbollah and is ready to assist troops in any ground operations. Information ...